Mesoblast - 53 Year Dividend History | MESO
Historical dividend payout and yield for Mesoblast (MESO) since 1971. The current TTM dividend payout for Mesoblast (MESO) as of November 29, 2024 is $0.00. The current dividend yield for Mesoblast as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.335B |
$0.006B |
|
Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's allogeneic, 'off-the-shelf' cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
